Egalet (EGLT) Misses Q2 EPS by 15c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to Egalet (EGLT) Misses Q2 EPS by 15c

Egalet (EGLT) Receives FDA Panel Recommendation for ARYMO ER for Pain Management

August 4, 2016 4:49 PM EDT

Egalet Corporation (Nasdaq: EGLT) announced that the joint meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee of the U.S. Food and Drug Administration (FDA) voted 18 to 1 to recommend approval of ARYMO ER (morphine sulfate). ARYMO ER was developed using Egalet's proprietary Guardian Technology for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

The committees also voted:

16 to 3 that if approved, ARYMO ER should... More

Egalet (EGLT) halted with news pending

August 4, 2016 6:55 AM EDT

Egalet (NASDAQ: EGLT) halted with news pending.

... More